# First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients

> **NCT01627860** · PHASE4 · COMPLETED · sponsor: **Johnson & Johnson Taiwan Ltd** · enrollment: 55 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** Topiramate add-on therapy
- **DRUG:** Topiramate monotherapy

## Key facts

- **NCT ID:** NCT01627860
- **Lead sponsor:** Johnson & Johnson Taiwan Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2013-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01627860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01627860, "First Add-on vs. Mono-therapy Study of Topiramate in Neuro-Surgical Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01627860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*